Affiliation:
1. From the Divisions of Hematology (P.T., A.L.) and Cardiology (C.R.B.), Department of Internal Medicine, University of Texas Health Sciences Center, Houston.
Abstract
Abstract
—β
2
-Glycoprotein I is a single-chain 50-kDa protein that circulates in plasma at a concentration of ≈200 μg/mL. Its physiological role remains uncertain, but an important clue is the frequent presence of antibodies to this protein in patients with recurrent thrombosis. We have isolated β
2
-glycoprotein I and examined its effect on the binding of phosphatidylserine (PS) vesicles by human monocyte–derived macrophages and by phorbol ester–stimulated THP-1 cells. β
2
-Glycoprotein I stimulated the binding of PS vesicles by these cells in a concentration-dependent manner. Vesicles containing other anionic phospholipids, such as cardiolipin, phosphatidic acid, or cardiolipin, inhibited the binding, whereas PC vesicles had no effect. Platelet-derived microvesicles, which contain anionic phospholipid on the outer leaflet of their phospholipid bilayer, also inhibited β
2
-glycoprotein I–dependent binding of anionic phospholipid vesicles. The binding is associated with incorporation of phospholipid in the cell membrane and internalization of β
2
-glycoprotein I. These findings suggest a physiological function for β
2
-glycoprotein I in the clearance of procoagulant anionic phospholipid-containing cell surfaces from the circulation.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献